about
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesThe outliers become a stampede as immunometabolism reaches a tipping pointBET domain co-regulators in obesity, inflammation and cancerA novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulatorBET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.Brd2 disruption in mice causes severe obesity without Type 2 diabetes.Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.Metabolic disease risk in children by salivary biomarker analysis.BET bromodomain inhibition as a novel strategy for reactivation of HIV-1Metabolic health reduces risk of obesity-related cancer in framingham study adults.Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease.Obesity genes and insulin resistance.Intrinsic Sex-Linked Variations in Osteogenic and Adipogenic Differentiation Potential of Bone Marrow Multipotent Stromal CellsBET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell.Diabetes and breast cancer mortality in Black women.'Metabolically healthy obesity': origins and implications.BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profileBarriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research.Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma.Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.Clinical trials for BET inhibitors run ahead of the science.The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis.Healthy obese persons: how can they be identified and do metabolic profiles stratify risk?Relationships Among Obesity, Type 2 Diabetes, and Plasma Cytokines in African American Women.Correction to "Barriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research"BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling.Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women.BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-mesenchymal Transition.Concanavalin A- and calcium-dependent phosphorylation of a protein of 80 kDa in mouse lymphocytes rendered permeable to exogenously added [gamma-32P]ATP.BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment."Obesity-Associated" Breast Cancer in Lean Women: Metabolism and Inflammation as Critical Modifiers of Risk.Inflammatory signatures distinguish metabolic health in African American women with obesity.Bcl-2, via Its BH4 Domain, Blocks Apoptotic Signaling Mediated by Mitochondrial RasThe Ca2+ release activities of D-myo-inositol 1,4,5-trisphosphate analogs are quantizedApoptosis during the development of radiogenic thymic lymphomas: effects of treatments inhibiting lymphoma developmentBRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK
P50
Q24673761-AAF7CE88-CA4A-4B53-B3AA-2FADB62F2534Q27005951-6F037739-1C2B-4DFD-A0E6-CD233D5F5599Q28269301-C927ED9C-2129-4AD0-9FDE-5B2E1CF90408Q28275590-A583E2E0-006D-4F58-936D-A917DD656109Q30248629-E1244AE2-46D6-4A64-A57A-A5FE266B784BQ33642188-1019FBBE-EE89-4D56-A70C-339D562C76BFQ33642463-0B82237C-D69A-4965-9856-0FBC497A784FQ33659363-AE1E7F8B-42E9-4B1E-8AD4-08DDC1297734Q33673921-5C5FB1A7-1A5A-49D8-B6D0-5B44FF18189DQ33733973-C19145EC-F6B8-4803-BAC8-16BAC99AC79BQ33733973-E98B8365-DEA3-4B60-BDFF-A36D9719AC9CQ34032827-CC7C7415-6CB1-494C-B647-58E49541D51DQ34287907-182BEFB7-F147-4B9B-88F4-42025713CF9BQ34611614-B94C110F-AC4C-433A-8A0E-76A0110A88A2Q34814601-4F580CB6-0115-4D54-A8D6-97807A847F58Q35050135-A6F63926-0C8D-4284-B880-044A795BBB87Q35967957-6AB0C781-2A98-46EA-83B6-7757FD833FACQ36229115-58E64F10-8989-428A-9E98-9C9ADC73EF53Q36641503-65B9F3CC-9210-4A6B-B583-96E19236D94FQ36718203-934DFEC2-68F4-4B3C-929F-FDDA82594098Q36729660-EAF6D34B-EB35-40F4-B90E-CDE0118B4257Q37097965-B0A42689-829B-48AF-8837-38C5E68A96A9Q37257101-8C65C12F-02ED-4195-8735-9C78026F1469Q37368735-7B6F27DC-0428-445B-9BB8-30658EA1D288Q37424181-68C701BF-5922-4482-B90D-202E3241B186Q37581436-99F511BF-7C3F-4224-B078-500F4B97C39BQ37602772-A3DAE37E-8BE9-4BEC-8758-B2775CFFEBD6Q40070652-6A4132A3-D0A9-4327-BDC0-153665074D65Q42395292-12E46476-5472-42B4-99C3-23D20513F87BQ43238483-6807D107-E435-49FD-8100-61DF83E42E79Q46919408-D63CB897-AAF3-4CCA-BA3F-140FF622DF09Q50043630-9B857A17-6820-4EC9-9A56-1564C8CD59E8Q50910806-448BCD01-755D-4647-A148-EBEBC9B76A1AQ52679779-C70A02CC-AFF8-47DB-A1C1-2AD1B65AF733Q53357661-1ABA79D1-256F-42DB-9450-727836758965Q55245739-6E5F0CC5-B807-4C4D-9935-BBBCDF2EFEB1Q57372098-3B91F81B-3F4C-426A-A8BB-C507DDF6688AQ67962678-7B3A84E7-F61E-49D2-9C1D-662BD1F10E64Q77703598-8D049464-AE2E-410D-8DED-944E37BF3D9DQ92171419-EDFDF1CF-92C8-417E-BB63-50A1D197B50A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gerald V Denis
@ast
Gerald V Denis
@en
Gerald V Denis
@es
Gerald V Denis
@nl
Gerald V Denis
@sl
type
label
Gerald V Denis
@ast
Gerald V Denis
@en
Gerald V Denis
@es
Gerald V Denis
@nl
Gerald V Denis
@sl
prefLabel
Gerald V Denis
@ast
Gerald V Denis
@en
Gerald V Denis
@es
Gerald V Denis
@nl
Gerald V Denis
@sl
P106
P31
P496
0000-0001-9886-0401